1. Home
  2. Animal Drug Index - T
  3. Thyrozine

Animal NDC 57319-455-43 Thyrozine

Levoxine

Animal Product Information

Field Name Field Value
Animal NDC Code 57319-455-43
Proprietary Name Thyrozine What is the Proprietary Name?
The proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
Non-Proprietary Name Levoxine What is the Non-Proprietary Name?
The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
Labeler Name Phoenix Pharmaceutical Inc./ Clipper Distributing, Inc.
Product Type Otc Animal Drug
Usage Information
    For use in horses and ponies for correction of conditions associated with low circulating thyroid hormone (hypothyroidism).
Active Ingredient(s)
  • Levothyroxine Sodium Anhydrous
Marketing Category UNAPPROVED DRUG OTHER What is the Marketing Category?
Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Thyrozine Images

Thyrozine Animal Product Labeling Information

The product labeling information includes all published material associated to a drug. Product labeling documents include information like generic names, active ingredients, ingredient strength dosage, routes of administration, appearance, usage, warnings, inactive ingredients, etc.

Table of Contents



Otc - Purpose



A Palatable Supplement for the Correction of Conditions Associated with Hypothyroidism in Horses and Ponies.


Otc - Keep Out Of Reach Of Children



KEEP OUT OF REACH OF CHILDREN
WARNING: Federal law restricts this drug to use by or on the order of a licensed veterinarian.


Indications:



For use in horses and ponies for correction of conditions associated with low circulating thyroid hormone (hypothyroidism).


Dosage:



Doses should be individualized and animals should be monitored daily for clinical signs of hyperthyroidism or hypersensitivity. Suggested
initial doses are 1–10 mg levothyroxine sodium (T4)/100 lb. body weight (2–20 mg/100 kg) once per day or in divided doses. Response to the administration of Thyrozine Powder should be evaluated clinically every week until an adequate maintenance dose is established. In most horses, this is usually in the range of 35 to 100 mg total daily dose of T4 (1–3 level tablespoonfuls Thyrozine Powder).


Composition:



Each pound (453.6 g) contains:
Levothyroxine Sodium USP.......... 0.22% (1.0 g)
One level teaspoonful contains 12 mg of T4; one level tablespoonful contains 36 mg of T4.


Warning:



Administer with caution to animals with clinically significant heart disease, hypertension or other complications for which a sharply increased metabolic rate might prove hazardous. Use in pregnant mares has not been evaluated.


Storage Conditions:



Do not store above 30°C (86°F). Keep lid tightly closed and store in a dry location.
USE ONLY AS DIRECTED


Net Contents:



1 lb (453.6 g)

10 lbs (4.5 Kg)


Information For Owners/Caregivers



Trademarks are property of Clipper Distributing Company, LLC
Manufactured by:
First Priority, Inc.
Elgin, IL U.S.A.


* The information on this page is for an ANIMAL PRODUCT, please review the complete disclaimer below.